Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)
NCT00744900
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DRUG:
Pemetrexed, cisplatin
Sponsor
University Hospital, Brest